Alzimer’s
Alzheimer's disease remains a critical area of research and public health concern, particularly as we move into 2024. Several significant reports and updates provide insights into various aspects of the disease, including its perception, economic impact, emerging treatments, and diagnostic criteria.
The 2024 World Alzheimer Report explores societal attitudes toward dementia, addressing the stigma associated with the condition and how it is understood by different communities. This report underscores the importance of greater awareness and acceptance of dementia in society. For more information, you can access the report here.
Additionally, the Alzheimer's Disease Facts and Figures report highlights the staggering economic implications of Alzheimer's and other dementias, with projected costs for health and long-term care expected to reach $360 billion in 2024. This figure does not include the value of unpaid care provided by families and friends, emphasizing the caregiving burden faced by many. To read more about these statistics, visit the full report here.
The 2024 Report to Congress addresses the role of immune cells in Alzheimer's disease and related dementias (AD/ADRD), marking advancements in understanding potential therapeutic targets and addressing cutting-edge clinical issues. For further details, the full report can be accessed here.
Reflecting on the past year, the 2024 update from the Alzheimer's Society captures exciting developments in research, including the announcement of new drugs and the activation of essential research partnerships aimed at transforming dementia care and understanding. More about these breakthroughs can be found here.
Looking ahead, insights into future treatments are provided in the 2024 forecast on Alzheimer's disease treatments. This document discusses new drugs, ongoing Phase 3 trials, and innovative therapies developing to combat the disease. For a closer look at what’s to come, visit the forecast here.
Moreover, Alzheimers.gov has announced a national plan update to address Alzheimer's Disease, highlighting ongoing efforts to improve care and support for those affected. For the latest news and events regarding this initiative, check out their updates here.
Lastly, the Alzheimer's Association has published updated criteria for the diagnosis and staging of Alzheimer's Disease, which includes a revised biomarker classification system, reflecting the latest research and clinical practices. Learn more about these updates here.
In summary, the resources from 2024 reflect a multifaceted approach to understanding and treating Alzheimer's disease, addressing both the societal impacts and scientific advancements that are continuously evolving in this critical field.
Sources
Related Questions
Work fast from anywhere
Stay up to date and move work forward with BrutusAI on macOS/iOS/web & android. Download the app today.